Jeffrey Katra, DO
Addiction Medicine · Charlottesville, VANPI 1558882860
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $48,685 of the $59,416 with a category attached, or 81.9%. AbbVie accounts for 85.2% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2023 at $38,614 and has fallen 80.6% since, to $7,504 in 2025. Among addiction medicine clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 106 payments — averaging $560.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$51K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$7K
- Neuronetics, Inc.$1K
- Phathom Pharmaceuticals, Inc.$95
- Shire North American Group Inc$11
What the payments were for
- Consulting fees$3,6886%
- Speaking & faculty fees$48,68582%
- Travel & lodging$5,1169%
- Food & beverage$1,9193%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 88 | $50,615 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $7,408 |
| Neuronetics, Inc. | 2 | $1,286 |
| Phathom Pharmaceuticals, Inc. | 1 | $95 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$48,662
- CAPLYTA$6,974
- NEUROSTAR TMS THERAPY SYSTEM$1,286
How this compares
$59,416 in reported general payments places this provider in the 95th percentile of 44 addiction medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 12 | $10,105 |
| MyrbetriqMirabegron | 14 | $7,835 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $6,001 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 16 | $1,115 |
| Atorvastatin Calcium | 84 | $1,026 |
| Mirtazapine | 71 | $985 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $761 |
| Duloxetine Hcl | 12 | $704 |
| Ventolin HfaAlbuterol Sulfate | 13 | $684 |
| Levothyroxine Sodium | 61 | $550 |
| Donepezil Hcl | 38 | $549 |
| Doxazosin Mesylate | 12 | $499 |
| Tamsulosin Hcl | 35 | $453 |
| Montelukast Sodium | 28 | $343 |
| Omeprazole | 57 | $319 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Charlottesville
- Masaru NishiaokiVirginia Beach$6K
- Gene GermanoNorfolk$3K
- Mitchell BurkenFredericksburg$3K
- Nancye SadlerManassas$3K
- Gilbert SchmidtVirginia Beach$3K
- James GardnerRichmond$1K
- Joshua MoranNorfolk$1K
- Reymond Damasco PascualHampton$958
- Ronald MejzakVirginia Beach$618
- Mary McMastersFishersville$528
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.